HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

tenecteplase

a triple combination mutant of alteplase developed to circumvent some of the limitations of fibrinolytic therapies
Also Known As:
Boehringer Ingelheim brand of tenecteplase; Genentech brand of tenecteplase; Hoffmann-La Roche brand of tenecteplase; Metalyse; TNKase
Networked: 220 relevant articles (31 outcomes, 73 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Van de Werf, Frans: 11 articles (06/2015 - 04/2003)
2. Gibson, C Michael: 10 articles (07/2005 - 04/2003)
3. Armstrong, Paul W: 9 articles (06/2015 - 08/2003)
4. Granger, Christopher B: 8 articles (01/2010 - 04/2003)
5. Giugliano, Robert P: 8 articles (03/2005 - 04/2003)
6. Harrington, Robert A: 8 articles (03/2005 - 04/2003)
7. Danays, Thierry: 7 articles (06/2015 - 01/2002)
8. Bogaerts, Kris: 6 articles (05/2011 - 07/2003)
9. Braunwald, Eugene: 6 articles (07/2005 - 04/2003)
10. Califf, Robert M: 6 articles (07/2005 - 04/2003)

Related Diseases

1. Myocardial Infarction
2. Stroke (Strokes)
3. Pulmonary Embolism
4. Hemorrhage
5. Thrombosis (Thrombus)

Related Drugs and Biologics

1. Tissue Plasminogen Activator (Alteplase)
2. Heparin (Liquaemin)
3. Enoxaparin (Lovenox)
4. abciximab (ReoPro)
5. TNK-tissue plasminogen activator
6. eptifibatide (Integrilin)
7. Glycoproteins (Glycoprotein)
8. Desmodus rotundus salivary plasminogen activator alpha 1
9. Streptokinase
10. Aspirin (Acetylsalicylic Acid)

Related Therapies and Procedures

1. Thrombolytic Therapy
2. Angioplasty (Angioplasty, Transluminal)
3. Blood Transfusion (Blood Transfusions)
4. Catheters
5. Cardiopulmonary Resuscitation (CPR)